4.6 Article

Activation of IRE1α-XBP1 pathway induces cell proliferation and invasion in colorectal carcinoma

期刊

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2015.12.119

关键词

ER stress; IRE1 alpha; Colorectal carcinoma; Cell proliferation; Epithelial-to-mesenchymal transition

资金

  1. Traditional Chinese Medicine Administration Bureau of Zhejiang Province, China [2015ZQ027]
  2. Science and Technology Bureau of Zhejiang Province, China [20140009]

向作者/读者索取更多资源

Cell proliferation and tumor metastasis are considered as the main reasons for death in colorectal carcinoma (CRC). IRE1 alpha-XBP1 pathway is the most conserved UPR pathways, which are activated during ER stress caused by the accumulation of unfolded or misfolded protein in the lumen of ER. Here, we demonstrated the critical role of IRE1 alpha-XBP1 pathway and underlying molecular mechanism in cell proliferation and tumor metastasis in CRC. By the use of tissue microarray analysis of samples from 119 patients with CRC, IRE1 alpha was determined to be an independent predictor of overall survival as higher expression of IRE1 alpha in CRC patients showed lower survival rates (p = 0.0041). RNA interference and ectopic expression of IRE1 alpha were applied to determine the molecular effects of IRE1 alpha in CRC cells. The silencing of IRE1 alpha inhibited the proliferation and blocked the invasion of CRC cells in vitro, while ectopic expression of IRE1 alpha in turn promoted cell proliferation and invasion. IRE1 alpha-XBP1 pathway regulated the mitosis of CRC cells through the directly binding of XBP1s to Cyclin D1 promoter to activate Cyclin D1 expression. Our results reveal that IRE1 alpha-XBP1 pathway plays an important role in tumor progression and epithelial-to-mesenchymal transition (EMT), and IRE1 alpha could be employed as a novel prognostic marker and a promising therapeutic target for CRC. (C) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据